Silicon Valley’s robust investment in anti-aging technologies is reshaping our future. ET Now Digital reports that pioneers like Altos Labs, backed by billionaires, are driving breakthroughs in cellular reprogramming and senolytics. Their work offers a glimpse into extended, healthier lives while raising concerns about equitable access.